Peter A. Meyers Insider Trading
Get free email notifications about insider trading for Peter A. Meyers.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter A. Meyers. Peter A. Meyers is a CFO & Treasurer in TETRALOGIC PHARMACEUTICALS CORP ($TLOG) and a Chief Financial Officer in EAGLE PHARMACEUTICALS, INC. ($EGRX).
Address: C/O TETRALOGIC PHARMACEUTICALS CORP 343 PHOENIXVLLE PIKE MALVERN 19355 PA
Companies in which Peter A. Meyers is an Insider
EAGLE PHARMACEUTICALS, INC.
Trading Symbol: EGRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A. Meyers: Chief Financial Officer
Holdings: 45,900 shares
Current Value: $3,187,296
Latest Transaction: Jan 07 2020
$EGRX Market Capitalization: $1.09B
$EGRX Previous Close: $69.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TETRALOGIC PHARMACEUTICALS Corp
Trading Symbol: TLOGIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A. Meyers: CFO & Treasurer
Holdings: 153,891 shares
Current Value: $9,233
Latest Transaction: Mar 31 2015
$TLOG Market Capitalization: $1.49M
$TLOG Previous Close: $0.06
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Peter A. Meyers
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Option Exercise | A | 59.80 | 48,000 | 2,870,160 | 48,000 | |
Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Payment of Exercise | F | 57.38 | 632 | 36,264 | 45,268 | 45.9 K to 45.3 K (-1.38 %) |
Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Grant | A | 0.00 | 19,500 | 0 | 45,900 | 26.4 K to 45.9 K (+73.86 %) |
Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Option Exercise | A | 42.40 | 43,200 | 1,831,680 | 43,200 | |
Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Grant | A | 0.00 | 19,300 | 0 | 26,400 | 7.1 K to 26.4 K (+271.83 %) |
Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Payment of Exercise | F | 41.33 | 600 | 24,798 | 7,100 | 7.7 K to 7.1 K (-7.79 %) |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Option Exercise | A | 0.00 | 21,000 | 0 | 21,000 |